🔎 Trials Near Me

Home › Steatotic Liver Disease › Michigan

Steatotic Liver Disease clinical trials in Michigan

8 studies for Steatotic Liver Disease are looking for participants at sites in Michigan.

Cities in Michigan

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

  • University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  • Clinical Research Institute of Michigan, LLC, Clinton Township
  • Great Lakes Research Institute, Southfield
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  • Akero Clinical Study Site, Novi
  • Akero Clinical Study Site, Southfield
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Ann Arbor
  • 89bio Clinical Study Site, Clinton Township
  • 89bio Clinical Study Site, Detroit
  • and 2 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chesterfield
  • 89bio Clinical Study Site, Wyoming
  • 89bio Clinical Study Site, Ypsilanti
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169

Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease

  • Henry Ford Health System, Detroit
Recruiting
Ages 30 to 70 · All sexes · Updated Aug 6, 2026 · NCT07646197

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

  • GSK Investigational Site, Detroit
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Aug 3, 2026 · NCT06613698

Thermoacoustic Method for Estimating Liver Fat Fraction

  • ENDRA Life Sciences, Ann Arbor
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT07321925

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.